LEARN MORE
Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.
LEARN MOREClinical Trials
Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.
Follow Us on Twitter
We thank @SenatorMensch for his co-sponsorship of #SB200, legislation to help PA mom & babies suffering from #PPD:… t.co/4STzhTK6cI
Retweeted by Marinus Pharma